Graf Akcie PIRS (Pieris Pharmaceuticals Inc). Diskuze k akciím PIRS. Aktuální informace PIRS.

Základní informace o společnosti Pieris Pharmaceuticals Inc (Akcie PIRS)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 262.95M
Hodnota podniku (EV) N/A
Tržby 23.734M
EBITDA N/A
Zisk -48.35
Růst v tržbách Q/Q -70.79 %
Růst v tržbách Y/Y -58.29 %
P/E (Cena vůči ziskům) 0.00
Forward P/E -0.55
EV/Sales 11.14
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 11.08
P/FCF N/A
Price/Book 8.47
Účetní hodnota na akcii 0.53
Hotovost na akcii 1.21
FCF vůči ceně -1.22 %
Počet zaměstnanců 117
Tržba na zaměstnance 202.855k
Profit margin -126.97 %
Operating margin -199.00 %
Gross margin 100.00 %
EBIT margin -203.04 %
EBITDA margin -58.41 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 177.78 %
EPS - Očekávaný růst příští rok -7.69 %
Return on assets -39.35 %
Return on equity -121.13 %
ROIC -30.12 %
ROCE -43.37 %
Dluhy/Equity 2.38
Čistý dluh/EBITDA 11.10
Current ratio 2.91
Quick Ratio 2.91
Volatilita 5.93
Beta 0.77
RSI 32.98
Cílová cena analytiků 8
Známka akcie (dle analytiků) 1.20
Insider ownership 11.59 %
Institutional ownership 57.03 %
Počet akcií 66.711M
Procento shortovaných akcií 1.66 %
Short ratio 0.63 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2015
Země United States

Finanční výsledky akcie PIRS

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$46.279$29.101$25.275$5.831$2.932$5.365$12.427
Cost Of Goods Sold-------
Gross Profit$46.279$29.101$25.275$5.831$2.932$5.365$12.427
Research And Development Expenses$54.996$41.49$22.285$19.699$8.245$5.6$9.412
SG&A Expenses$18.44$18.442$17.584$8.891$8.368$6.963$2.462
Other Operating Income Or Expenses-------
Operating Expenses$73.436$59.932$39.869$28.59$16.613$12.563$11.874
Operating Income$-27.157$-30.831$-14.594$-22.759$-13.681$-7.198$0.554
Total Non-Operating Income/Expense$1.688$3.765$-1.95$0.122$-0.174$-2.652$-0.488
Pre-Tax Income$-25.469$-27.066$-16.544$-22.637$-13.855$-9.85$0.066
Income Taxes-$-0.312$1.103$0.162$0.204--
Income After Taxes$-25.469$-26.754$-17.647$-22.799$-14.059$-9.85$0.066
Other Income-------
Income From Continuous Operations$-25.469$-26.754$-17.647$-22.799$-14.059$-9.85$0.066
Income From Discontinued Operations-------
Net Income$-28.299$-26.754$-17.647$-22.799$-14.059$-9.85$0.066
EBITDA$-26.525$-30.261$-14.225$-22.398$-13.373$-6.831$0.939
EBIT$-27.157$-30.831$-14.594$-22.759$-13.681$-7.198$0.554
Basic Shares Outstanding51534442341412
Shares Outstanding51534442341412
Basic EPS$-0.56$-0.50$-0.40$-0.55$-0.41$-0.71$0.01
EPS - Earnings Per Share$-0.56$-0.50$-0.40$-0.55$-0.41$-0.71$0.01
# 2020 2019 2018 2017 2016 2015
Current Ratio4.25932.8161.96163.898911.31585.631
Long-term Debt / Capital------
Debt/Equity Ratio-----0.0706
Gross Margin100100100100100100
Operating Margin-58.681-105.9448-57.7409-390.3104-466.622-134.1694
EBIT Margin-58.681-105.9448-57.7409-390.3104-466.622-134.1694
EBITDA Margin-57.3154-103.9861-56.2809-384.1194-456.1201-127.3292
Pre-Tax Profit Margin-55.0336-93.0071-65.456-388.2181-472.5478-183.5952
Net Profit Margin-61.1487-91.935-69.82-390.9964-479.5011-183.5949
Asset Turnover0.3280.20590.24330.16630.08640.2455
Inventory Turnover Ratio------
Receiveable Turnover6.818810.77421.6258102.2982--
Days Sales In Receivables53.528733.8774224.50213.568--
ROE - Return On Equity-49.5969-66.9939-153.1593-90.3754-45.1636-54.7025
Return On Tangible Equity-49.5969-66.9939-153.1591-90.3754-45.1635-54.7025
ROA - Return On Assets-18.0507-18.9287-16.9885-65.023-41.4098-45.0642
ROI - Return On Investment-49.5969-66.9939-153.1592-90.3754-45.1636-54.7025
Book Value Per Share0.93010.73750.25590.58590.78150.615
Operating Cash Flow Per Share-1.0163-1.15261.47740.0245-0.0042-0.1051
Free Cash Flow Per Share-1.0329-1.14031.44660.0291-0.0031-0.1201